AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

AnaptysBio’s Phase IIb trial of its rheumatoid arthritis (RA) treatment, rosinilimab, has seen some patients achieve the ...

ANSWER: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an overlap ...

Anesthesia does not cause dementia. However, some people do develop a complication called post-operative delirium.

My husband, who is 71, has been having some short-term memory problems over the past two years. We recently saw his primary doctor, who asked him some questions ...

Dear D.D.: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an overlap syndrome as it has features that resemble lupus, systemic sclerosis ...

My husband, who is 71, has been having some short-term memory problems over the past two years. We recently saw his primary doctor, who asked him some questions and had him do a few tasks. He did fail ...

The Trump administration’s efforts to curb research funding has put treatment for 9/11 first responders, studies of top causes of death in older women, and other life-saving programs on college ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...